Abstract B112: Mast cell cross-talk with primary and metastatic pancreatic tumor cells
Pancreatic ductal adenocarcinoma (PDAC), notorious for its fatality, claims a five-year survival rate of around 13%. PDAC is projected to become the second leading cause of cancer-related deaths by 2030. PDAC is often diagnosed at the advanced stage, where the tumor has spread to distant organs such as the liver and...